CG Oncology

CGON · NASDAQ

$61.93+$1.97 (+3.29%)TodayMarket closed ·
Prev close $59.96

Who owns CGON

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 58.1% of CGON’s shares.

  • RTW Investments L.P.9.7%
  • T. Rowe Price Investment Management, Inc.7.5%
  • Decheng Capital LLC7.2%
  • BlackRock Institutional Trust Company, N.A.6.2%
  • Next 6 largest institutions27.5%
  • All other shareholders41.9%
Top institutional holders of CGON
HolderShares% of shares
RTW Investments L.P.8.51M9.65%
T. Rowe Price Investment Management, Inc.6.62M7.50%
Decheng Capital LLC6.37M7.22%
BlackRock Institutional Trust Company, N.A.5.43M6.16%
Wellington Management Company, LLP5.32M6.04%
Longitude Capital Management Co., LLC4.66M5.29%
T. Rowe Price Associates, Inc.3.71M4.20%
TCG Crossover Management, LLC3.67M4.16%
Vanguard Portfolio Management, LLC3.47M3.93%
Foresite Capital Management, LLC3.45M3.91%

Largest mutual fund holders

Top mutual fund holders of CGON
HolderShares% of shares
Vanguard Health Care Fund2.86M3.24%
T. Rowe Price Capital Appreciation Fund2.54M2.88%
Vanguard Total Stock Market Index Fund2.39M2.71%
State Street SPDR S&P Biotech ETF1.91M2.17%
iShares Russell 2000 ETF1.90M2.15%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $2.88M (9 trades) of CGON on the open market, with no buys.

Latest CGON insider transactions
InsiderTypeSharesValue
POST LEONARD EOption exercise1.00K—
POST LEONARD ESale1.00K$72.98K
POST LEONARD EOption exercise1.00K$600
POST LEONARD EOption exercise1.00K—
POST LEONARD ESale1.00K$74.54K
POST LEONARD EOption exercise1.00K$600
POST LEONARD EOption exercise1.00K—
POST LEONARD ESale1.00K$71.17K
POST LEONARD EOption exercise1.00K$600
Mulay JamesOption exercise24.16K—

Short interest

Settled Sep 30, 2026

Shares short
10.44M
Days to cover
8.46
% of shares outstanding
11.84%
Average daily volume
1.23M
Change since last report
−7.2%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.